Eli Lilly and Company
Prescription Drugs · Cardiometabolic Therapeutics

Eli Lilly and Company: Ownership & structure

Eli Lilly Group Limited holds 75–100% of Eli Lilly and Company.

Data updated Nov 22, 2026 · Back to the company report

Owners & entities

Eli Lilly Group Limited holds 75–100% of Eli Lilly and Company.

Holders
Eli Lilly Group Limited
ownership of shares 75 to 100 percent; voting rights 75 to 100 percent; right to appoint and remove directors as firm; significant influence or control as firm · find-and-update.company-information.service.gov.uk ↗
75–100%
Legal entities4 in 3 countries
Eli Lilly and Company
operator · US EIN 350470950
US
subsidiary · IE CRO 590814
IE
subsidiary · IE CRO 171214
IE
subsidiary · GB CRN 00284385
GB
Subsidiaries in its annual report: 158 in 58 jurisdictions · Delaware 48, Indiana 7, Spain 6, Cayman Islands 5, Switzerland 5 · sec.gov ↗
Stakes and purchases
subsidiary (stated on the holder)
subsidiary (stated on the holder)
subsidiary (stated on the holder)
Large holders (13D / 13G)holders of 5% or more, their newest filing
LILLY ENDOWMENT INC
passive holder · SCHEDULE 13G/A · Oct 2026
VANGUARD CAPITAL MANAGEMENT LLC
passive holder · SCHEDULE 13G · May 2026
VANGUARD GROUP INC
passive holder · SCHEDULE 13G/A · Mar 2026
PNC FINANCIAL SERVICES GROUP, INC.
passive holder · SCHEDULE 13G/A · Feb 2025
Insider tradesopen-market buys and sales on SEC Form 4, last 12 months

Insiders bought $0 (0 people) and sold $696M (5 people) in the last 12 months.

Sold · EVP & President, LLY Int'l
6,500 shares at $1,175.10 · Aug 2026
$7.6M
Sold · SVP, Finance, & CAO
2,000 shares at $1,185.01 · Aug 2026
$2.4M
Sold · EVP, GC & Secretary
5,000 shares at $1,190.00 · Aug 2026
$6M
Sold · EVP&Pres, LLY USA&Global Capab
2,500 shares at $1,150.77 · Jun 2026
$2.9M
Sold · LILLY ENDOWMENT INC · Other
13,620 shares at $995.23 · May 2026
$13.6M
Sold · LILLY ENDOWMENT INC · Other
2,208 shares at $996.18 · May 2026
$2.2M
Sold · LILLY ENDOWMENT INC · Ten Percent Owner
40,956 shares at $1,103.31 · Jan 2026
$45.2M
Sold · LILLY ENDOWMENT INC · Ten Percent Owner
34,434 shares at $1,102.41 · Jan 2026
$38M
Sold · LILLY ENDOWMENT INC · Ten Percent Owner
24,362 shares at $1,105.46 · Jan 2026
$26.9M
Sold · LILLY ENDOWMENT INC · Ten Percent Owner
21,042 shares at $1,104.40 · Jan 2026
$23.2M
Holders and shares as each register or filing states them.

Connections

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors4
Aditum BioVia a fund
5 portfolio companies: Oblenio Bio, Kalexo Bio, Via Nova 2.0 and 2 more
28 portfolio companies: Johnson & Johnson, Smith+Nephew, Eledon and 25 more
222 portfolio companies: Verdiva Bio, PLEASE READ THIS AG, Vivace Therapeutics and 219 more
Kleiner PerkinsVia a fund
340 portfolio companies: Isomorphic Labs, Nidus, Ancep and 337 more
Show all 4